Literature DB >> 16598425

Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.

Maria Fleseriu1, Michael Lee, Maria M Pineyro, Mario Skugor, Sethu K Reddy, Elias S Siraj, Amir H Hamrahian.   

Abstract

The authors report a case of a patient with giant, invasive skull base tumor extending to the parasellar area discovered incidentally during the work-up for decreased memory. The patient's neurological exam was otherwise unremarkable. Endocrine evaluation performed at a local hospital showed a moderate hyperprolactinemia 103 ng/ml (normal up to 20 ng/ml). Given the large size of the tumor, the elevated prolactin (PRL) was interpreted to be secondary to stalk effect and patient underwent debulking surgery through a transcranial approach. Immunostaining of the excised tumor tissue was strongly positive for prolactin. His prolactin was found to be 13,144 ng/ml in our lab after surgery confirming the diagnosis of invasive giant prolactinoma. The patient developed a complete right third, fourth and sixth nerve palsy postoperatively. He was started on Cabergoline with normalization of his prolactin level and more than 50% decrease in residual tumor size over 9 months periods. There has been no clinically significant improvement in his right eye ophthalmoplegia since surgery. This case highlights the importance of 'Hook Effect' resulting in falsely low prolactin level, which may have significant therapeutic implication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598425     DOI: 10.1007/s11060-005-9108-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  Automated prozone effect detection in ferritin homogeneous immunoassays using neural network classifiers.

Authors:  K Papik; B Molnar; P Fedorcsak; R Schaefer; F Lang; L Sreter; J Feher; Z Tulassay
Journal:  Clin Chem Lab Med       Date:  1999-04       Impact factor: 3.694

2.  Dilution protocols for detection of hook effects/prozone phenomenon.

Authors:  A W Butch
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

3.  The hook effect in prolactin immunoassays.

Authors:  Saud N Al Sifri; Hussein Raef
Journal:  Saudi Med J       Date:  2004-05       Impact factor: 1.484

4.  Two automated prolactin immunoassays evaluated with demonstration of a high-dose "hook effect" in one.

Authors:  B L Haller; K A Fuller; W S Brown; J W Koenig; B J Eveland; M G Scott
Journal:  Clin Chem       Date:  1992-03       Impact factor: 8.327

5.  "High-dose hook effect" in IRMA-Count PSA assay of prostate-specific antigen.

Authors:  D S Ooi; E A Escares
Journal:  Clin Chem       Date:  1991-05       Impact factor: 8.327

6.  Potential hook effect in prolactin assay in patients with giant prolactinoma.

Authors:  E Delgrange; R de Hertogh; L Vankrieken; D Maiter
Journal:  Clin Endocrinol (Oxf)       Date:  1996-10       Impact factor: 3.478

7.  High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.

Authors:  E St-Jean; F Blain; R Comtois
Journal:  Clin Endocrinol (Oxf)       Date:  1996-03       Impact factor: 3.478

8.  High-dose "hook" effect in measurement of somatotropin by two-site immunoradiometric assay.

Authors:  P Garcia-Webb; F E Watson; N Whiteside
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

9.  Falsely low serum prolactin in two cases of invasive macroprolactinoma.

Authors:  Christof Schöfl; Beate Schöfl-Siegert; Johann Hinrich Karstens; Michael Bremer; Thomas Lenarz; Jose Sebastian Fernandez Cuarezma; Madjid Samii; Alexander von zur Mühlen; Georg Brabant
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

10.  [Thyroglobulin assay ambiguities].

Authors:  R Sapin; J L Schlienger
Journal:  Ann Biol Clin (Paris)       Date:  1998 Jan-Feb       Impact factor: 0.459

View more
  12 in total

Review 1.  Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.

Authors:  Avital Perry; Christopher Salvatore Graffeo; Christopher Marcellino; Bruce E Pollock; Nicholas M Wetjen; Fredric B Meyer
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-24

2.  Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist.

Authors:  Moon Sool Yang; Jae Won Hong; Seung Koo Lee; Eun Jig Lee; Sun Ho Kim
Journal:  J Neurooncol       Date:  2010-11-24       Impact factor: 4.130

3.  Prolactin immunoassay: does the high-dose hook effect still exist?

Authors:  Véronique Raverot; Pauline Perrin; Philippe Chanson; Emmanuel Jouanneau; Thierry Brue; Gérald Raverot
Journal:  Pituitary       Date:  2022-07-06       Impact factor: 3.599

Review 4.  The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry.

Authors:  Andrew N Hoofnagle; Mark H Wener
Journal:  J Immunol Methods       Date:  2009-06-16       Impact factor: 2.303

5.  Cognitive Function and Serum Hormone Levels Are Associated with Gray Matter Volume Decline in Female Patients with Prolactinomas.

Authors:  Shun Yao; Jian Song; Junfeng Gao; Pan Lin; Ming Yang; Kashif Rafiq Zahid; Yan Yan; Chenglong Cao; Pan Ma; Hui Zhang; Zhouyue Li; Cheng Huang; Huichao Ding; Guozheng Xu
Journal:  Front Neurol       Date:  2018-01-29       Impact factor: 4.003

6.  Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery.

Authors:  Yan-Long Han; Dong-Ming Chen; Cheng Zhang; Miao Pan; Xiao-Peng Yang; Yong-Gang Wu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

7.  Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.

Authors:  Nicholas A Tritos; Pouneh K Fazeli; Ann McCormack; Susana M Mallea-Gil; Maria M Pineyro; Mirjam Christ-Crain; Stefano Frara; Artak Labadzhyan; Adriana G Ioachimescu; Ilan Shimon; Yutaka Takahashi; Mark Gurnell; Maria Fleseriu
Journal:  Pituitary       Date:  2021-07-20       Impact factor: 4.107

8.  A lifelong smoker with hypopituitarism: rethinking the hypothesis of a tumor in the hypophysis.

Authors:  Nestoras Mathioudakis; Alfredo Quinones-Hinojosa; Roberto Salvatori; Shehzad Basaria
Journal:  Case Rep Med       Date:  2012-04-22

9.  Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate.

Authors:  Lilie L Lin; Rosemarie Mick; Jeffrey Ware; James Metz; Robert Lustig; Neha Vapiwala; Ramesh Rengan; Ann R Kennedy
Journal:  Oncol Lett       Date:  2014-02-05       Impact factor: 2.967

10.  Chronic cluster-like headache in a patient with a macroprolactinoma presenting with falsely low prolactin levels: bromocriptine versus cabergoline?

Authors:  Maria M Pineyro; Gabriela Sosa; Maria R Finozzi; Natalia Stecker; Raul Pisabarro; Maria C Belzarena
Journal:  Clin Case Rep       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.